Altimmune（NASDAQ:ALT）报告2024年第四季度每股亏损为$(0.33)，符合分析师的共识预期。相比去年同期每股亏损$(0.54)，亏损减少了38.89%。公司本季度报告收入为$5.00千，与去年同期的$37.00千相比下降了86.49%。

以上内容来自Benzinga Earnings专栏，原文如下：

Altimmune (NASDAQ:ALT) reported quarterly losses of $(0.33) per share which met the analyst consensus estimate. This is a 38.89 percent increase over losses of $(0.54) per share from the same period last year. The company reported $5.00 thousand in sales this quarter. This is a 86.49 percent decrease over sales of $37.00 thousand the same period last year.